$80,000 of INCYTE CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act."
You can find more data on corporate lobbying on Quiver Quantitative.
INCY Congressional Stock Trading
Members of Congress have traded $INCY stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $INCY stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
INCY Insider Trading Activity
INCY insiders have traded $INCY stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $INCY stock by insiders over the last 6 months:
- STEVEN H STEIN (EVP & Chief Medical Officer) has made 0 purchases and 2 sales selling 18,658 shares for an estimated $1,275,549.
- SHEILA A. DENTON (EVP & General Counsel) has made 0 purchases and 11 sales selling 12,637 shares for an estimated $968,297.
- BARRY P FLANNELLY (EVP & General Manager US) has made 0 purchases and 3 sales selling 13,435 shares for an estimated $917,914.
- VIJAY K IYENGAR (EVP, GMAPPS) has made 0 purchases and 4 sales selling 10,777 shares for an estimated $736,698.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
INCY Hedge Fund Activity
We have seen 344 institutional investors add shares of INCY stock to their portfolio, and 301 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,390,084 shares (+701.8%) to their portfolio in Q2 2025, for an estimated $162,764,720
- AQR CAPITAL MANAGEMENT LLC added 1,465,286 shares (+21.8%) to their portfolio in Q2 2025, for an estimated $99,785,976
- PACER ADVISORS, INC. added 1,233,399 shares (+8091.6%) to their portfolio in Q3 2025, for an estimated $104,604,569
- MARSHALL WACE, LLP added 1,211,231 shares (+inf%) to their portfolio in Q2 2025, for an estimated $82,484,831
- ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. added 995,204 shares (+71.5%) to their portfolio in Q2 2025, for an estimated $67,773,392
- SG AMERICAS SECURITIES, LLC added 910,044 shares (+2325.7%) to their portfolio in Q2 2025, for an estimated $61,973,996
- HSBC HOLDINGS PLC removed 678,906 shares (-64.8%) from their portfolio in Q2 2025, for an estimated $46,233,498
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INCY Analyst Ratings
Wall Street analysts have issued reports on $INCY in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 09/22/2025
- B of A Securities issued a "Buy" rating on 09/04/2025
- BMO Capital issued a "Underperform" rating on 07/30/2025
- Citigroup issued a "Buy" rating on 07/30/2025
To track analyst ratings and price targets for INCY, check out Quiver Quantitative's $INCY forecast page.
INCY Price Targets
Multiple analysts have issued price targets for $INCY recently. We have seen 11 analysts offer price targets for $INCY in the last 6 months, with a median target of $89.0.
Here are some recent targets:
- Jessica Fye from JP Morgan set a target price of $89.0 on 10/09/2025
- Brian Abrahams from RBC Capital set a target price of $81.0 on 09/24/2025
- Stephen Willey from Stifel set a target price of $115.0 on 09/22/2025
- Tazeen Ahmad from B of A Securities set a target price of $104.0 on 09/04/2025
- Derek Archila from Wells Fargo set a target price of $89.0 on 08/06/2025
- Luke Sergott from Barclays set a target price of $90.0 on 08/01/2025
- Nicholas Holowko from UBS set a target price of $68.0 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
